Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation

Authors:

Abstract
No abstract available
Funding Information
  • Boehringer Ingelheim
  • Portola Pharmaceuticals

This publication has 28 references indexed in Scilit: